Rectal neuroendocrine tumor
Conditions
Interventions
Experimental group:Endoscopic intermuscular dissection for the management of rectal neuroendocrine tumors
Control group:Endoscopic submucosal dissection for rectal neuroendocrine tumor?
Sponsors
South China Hospital of Shenzhen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Chinese population aged 18-80 years; 2.Endoscopic examination suggests a rectal lesion; 3.Endoscopic ultrasonography (EUS) was performed before surgery, with the lesion diameter judged to be 10-20mm and the invasion depth being the submucosal layer and/or the muscularis mucosae; 4.Pelvic and abdominal MRI scan + enhancement and/or 68GaPET-CT examination before surgery to exclude lymph node and distant metastasis; 5.The subjects are willing to receive treatment and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Imaging studies revealed distant metastasis or lymph node enlargement. 2.Pregnant and lactating women; 3.Severe coagulation dysfunction; 4.The presence of concurrent severe diseases, such as malignant tumors, makes the patient unable to tolerate surgical treatment. 5.Postoperative pathological results confirm that it is not a neuroendocrine tumor. 6.Combined with severe diseases of the heart, lungs, kidneys, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical success;R0 recession rate;Whole block resection rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical time;Hospital stay;Bleeding;Perforation;Hospitalization costs.;Pathological grading.;Horizontal margin.;Vertical margin.; | — |
Countries
China
Contacts
Public ContactSilin Huang
South China Hospital of Shenzhen University
Outcome results
None listed